SYRE logo
Spyre Therapeutics, Inc.(SYRE)
Last print unknown agoAbout this dataData status
$84.72▲4.82 (6.03%)Stale · unknown oldEarnings · Nov 3

SYRE Common Stock

$16.00KQuarterly · USD

Period ending:

SYRE FY Common StockUSD
SYRE FY Common Stock2013-12-31: $664.00K2014-12-31: $811.00K2015-12-31: $0.002016-12-31: $1.00K2017-12-31: $2.00K2018-12-31: $2.00K2019-12-31: $3.00K2020-12-31: $5.00K2021-12-31: $5.00K2022-12-31: $6.00K2023-12-31: $10.00K2024-12-31: $13.00K2025-12-31: $15.00K$811.00K$0.00
2013-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

SYRE common stock history

Par value of issued common shares. The available annual fiscal periods series contains 13 observations from Dec 31, 2013 to Dec 31, 2025.

Spyre Therapeutics Inc Common Stock — Annual fiscal periods (USD)
Period endingCommon Stock (USD)
15,000
13,000
10,000
6,000
5,000
5,000
3,000
2,000
2,000
1,000
0
811,000
664,000

Compare common stock

All SYRE financial metrics · SYRE stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.